Product Review of PharmaCircle: Sources, Content and Coverage
Jinfo Article
24th March 2014
Abstract
In the second part of our review of PharmaCircle, an online resource for professionals in the biopharmaceutical industry, Yulia Aspinall looks at how it covers information needs at all stages of the drug research, development and marketing process. The "living" database includes international coverage with some documents translated and made searchable.
Content Access
Does your organisation have a Jinfo Subscription?
Access to Jinfo Content and Community is available through a Jinfo Subscription.
"Yes"
Please sign in to MyJinfo here so that we can check your access to this item:
Or sign in via email:
Enter your email and we'll send you a magic link to sign you in automatically.
"Not yet"
Access to this article is available through a Jinfo Subscription, which will help your organisation:
- Save time and money
- Re-invent information services
- Define, measure and communicate information value.
"Don't know"
Contact us to find out if your organisation already has a Jinfo Subscription.
Or use the 'Text Chat' button at the bottom-right of this page for immediate assistance.
- Article title: Product Review of PharmaCircle: Sources, Content and Coverage
- Link to this page
- View printable version
- Product Review of PharmaCircle: Value, Development, Help & Pricing
Wednesday, 26th March 2014 - Product Review of PharmaCircle: Technology - Search; Outputs & Alerts; User Interface
Tuesday, 25th March 2014 - Product Review of PharmaCircle: Introduction & Contact Details
Friday, 21st March 2014 - Mini Review: F1000Prime
Thursday, 27th February 2014 - Merger Mania in Biopharma: Will Information Professionals be Victims, Witnesses or Winners?
Friday, 20th December 2013 - Product Review of InfoNgen: Executive Summary
Tuesday, 17th December 2013 - Mini Review: IngentaConnect
Friday, 13th December 2013 - Mini Review: Best Practices LLC
Tuesday, 17th September 2013
- Biopharma: Translation Tools Come of Age
Tuesday, 21st January 2014 - Biopharma Companies in a State of Flux
Friday, 2nd August 2013